Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Y. K Hamied : Changing the Dialogue
Y.K. Hamied, PhD, Chairman, Cipla
Fred Frank: Fortune and the Financier
Fred Frank, Vice Chairman, P.J. Solomon Co.
Marck McLellan: An 'A' for Advancing Expectations
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
Inside the Mind of the CEO: Steve Collis
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
Atsushi Nagahisa: Creating Customer Value
Atsushi Nagahisa, President & CEO, RaQualia
Physicians: Still the Vital Connection in Medicine
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
Henry Waxman: "Representing" Healthcare to the Fullest
Henry Waxman, Congressional Representative from Los Angeles, California
IP: Securing a Global Consensus—Can Industry Do It Again?
Harvey Bale, Jr., MD, former Director-General, IFPMA
In Establishing the Evidence Base, He Made Science Count
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Jane Henney: Lessons from the FDA Front Line
Jane Henney, MD, Former FDA Commissioner
P. Roy Vagelos: Getting to No. 1—and Staying There
P. Roy Vagelos, MD, Chairman Emeritus, Merck
Emerging Markets:The Myths and Traps
Success in the emerging markets depends significantly on navigating the myths and mental traps.
Patient Advocacy: The Last 30 Years
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Pharm Exec: 30 Years, 30 Leaders
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
Francis Collins: Guiding a Revolution in Science
Francis Collins, MD, PhD, Director, National Institutes of Health
Napoleone Ferrara: Curative Powers of Collaboration
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
Martin Wygod: Arming up for the Digital Revolution
Martin Wygod, Chairman, WebMD
Sidney Wolfe: Pharma's Unlikely Best Friend
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
Janet Woodcock: At the Helm of Industry
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
Sir Michael Rawlins: Regulation and Reputation
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
Josef von Rickenbach: The Enterprising CRO
Josef von Rickenbach, President & CEO, Parexel
Peter Piot: The Crisis Manager
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
Sir Martin Sorrell: Teamwork and Trust
Sir Martin Sorrell, CEO, WPP
Fernand Sauer: The Essential—and Effective—Bureaucrat
Fernand Sauer, First Director General, European Medicines Agency
Productivity, Reputation are Keys to Global Leadership
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
Sweden: Setting the Pace for Global Pharma
Garbo gets it ...
Henry Grabowski: Academia Sweet Spot
Henry Grabowski, PhD, Professor of Economics, Duke University
Romania: Staking its Claim
Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.
Partnering with the New Players
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
